Slowly marching forwardWe have a long road ahead till phase 2 is completed. Hopefully results will be a very high efficacy rate. News yesterday certainly didn't do much so I wonder if this won't trend downwards into the 40s or high 30s while we wait for trial results. There seems to be some competition and first to market can be a significant factor in success. Just my idle thoughts as I hold and wait for results over the next year and two. I also wonder if they go the route of just licensing this to various centers, then it wouldn't be too much of a boost to the share price. I would love to see a high valuation if this trial succeeds with a high efficacy rate. Have no idea what that price would be tho. Would we.be looking at $2 to $5...or would this be $30 to $50. Well...onwards and hopefully many cancer patients will one day be alive due to TLT.